| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 05/31/2006 | CN1778348A Danshen freeze-drying injection for treating cardiovascular and cerebrovascular diseases and preparation thereof |
| 05/31/2006 | CN1778325A Disperse tablet for activating bood and stopping pain and its preparation |
| 05/31/2006 | CN1778299A Cavitas nasisal cavity medicine-supply preparation with radix aconiti agrestis methyl |
| 05/31/2006 | CN1257969C Polygonum capilalum extract , its preparation method and use |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/31/2006 | CN1257747C Medicinal liquor for treating rheumatism |
| 05/31/2006 | CN1257719C Application of cnidium oil in preparing medicine for treating cerebral thrombus and headache |
| 05/31/2006 | CN1257718C Chinese traditional medicine composition and its preparation and quality control method thereof |
| 05/30/2006 | USRE39113 Neuropathic pain; in humans, animals |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |
| 05/30/2006 | US7053230 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053089 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate (NMDA) |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053050 administering erythropoietin receptor antagonist or mimetics thereof |
| 05/30/2006 | US7052906 Synthetic transmembrane components |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052850 Isolated human EDG-4 receptor |
| 05/30/2006 | US7052714 Ophthalmic adhesive preparations for percutaneous adsorption |
| 05/30/2006 | US7052702 comprises a light-chain or a heavy-chain fragment of a Pseudonomas neurotoxin with a proteolytically active enzyme domain; N-acetylgalactosamine-binding lectins; to inhibit the release of neurotransmitters from neurons thereby reducing and/or preventing transmission of afferent pain signals |
| 05/30/2006 | US7052700 Treating gynecological blood stasis, cardio-cerebral vascular diseases, respiratory system and urinary system diseases |
| 05/30/2006 | US7052688 At least one strain of hydrogen peroxide-producing lactic acid bacteria, and at least one strain of arginine-utilizing lactic acid bacteria; treatment of infections and inflammatory conditions caused by bacteria, viruses, fungi |
| 05/30/2006 | US7052686 Pegylated interleukin-10 |
| 05/30/2006 | US7052684 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | US7052674 Prokineticin polypeptides, related compositions and methods |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 05/30/2006 | CA2263663C Substituted gamma aminobutyric acids as pharmaceutical agents |
| 05/26/2006 | WO2006054793A1 Benzofuran compound and pharmaceutical composition containing the same |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054691A1 Soluble protein and utilization of the same |
| 05/26/2006 | WO2006054641A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | WO2006054514A1 Preventive or therapeutic pharmaceutical composition for neuropathic pain |
| 05/26/2006 | WO2006054513A1 Preventive or therapeutic agent for neuropathic pain |
| 05/26/2006 | WO2006054319A2 Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins |
| 05/26/2006 | WO2006053784A2 1,7-naphthyridines as pde4 inhibitors |
| 05/26/2006 | WO2006053766A1 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol |
| 05/26/2006 | WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | WO2006053556A1 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis |
| 05/26/2006 | WO2006053390A1 A method of modulating b cell functioning |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006019586A3 Method of treating trauma or sepsis |
| 05/26/2006 | WO2006016237A3 Heterocyclic derivatives as anti-inflammatory agents |
| 05/26/2006 | WO2006015590A3 Novel formulation for l-tryptophane comprising carbidopa/benserazide |
| 05/26/2006 | CA2589001A1 Preventive or therapeutic agent for neuropathic pain |
| 05/26/2006 | CA2588513A1 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 05/26/2006 | CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | CA2587957A1 Methods for purifying trans-(-)-delta-9-tetrahydrocannabinol and trans-(+)-delta-9-tetrahydrocannabinol |
| 05/26/2006 | CA2587731A1 Anti-inflammatory extract and agent and method for the production thereof |
| 05/26/2006 | CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | CA2587407A1 A method of modulating b cell functioning |
| 05/26/2006 | CA2587398A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | CA2584222A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | CA2572302A1 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111431 Thiophene carboxanmides as inhibitors of the enzyme ikk-2 |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111418 Blood-brain barrier disruption inhibitor |
| 05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111326 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 05/25/2006 | US20060111292 Using gene-regulatory peptide |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060110465 Compositions addressing inflammation and/or degenerative disorders |
| 05/25/2006 | US20060110394 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110332 Agent for medicamentous treatment of acute and chronic pain |
| 05/24/2006 | EP1659125A1 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659111A2 Piperidine derivatives useful as ccr5 antagonists |
| 05/24/2006 | EP1658860A1 Drug compositions comprising anticholinergics and EGFR kinase inhibitors |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | EP1658086A2 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 05/24/2006 | EP1658083A1 Enhancement of activity and/or duration of action of selected anti-inflammatory steroids |
| 05/24/2006 | EP1658065A2 Using selective antagonists of persistent sodium current to treat neurological disorders and pain |